PI-RADSv2 Category on 3 Tesla Multiparametric Prostate MRI Predicts Oncologic Outcomes in Gleason 3+4 Prostate Cancer on Biopsy

3TmpMRI with PI-RADSv2 scoring is a common tool in prostate cancer (PCa) diagnosis and informs the likelihood of a cancerous lesion. We sought to investigate whether PI-RADSv2 also predicts adverse pathologic (AP) features mainly in patients with biopsy Gleason score (GS) 3+4.

Source: The Journal of Urology - August 22, 2018 Category: Urology & Nephrology Authors: Izak Faiena, Amirali Salmasi, Neil Mendhiratta, Daniela Markovic, Preeti Ahuja, William Hsu, David A. Elashoff, Steven S. Raman, Robert E. Reiter Source Type: research